APP and Alzheimer disease: In the pathological changes of AD, Fe65 (a ligand of APP) binds to the intracellular subdomain of APP (AICD), and their interaction in the nervous system significantly increases the transfer of APP to the cell surface as well as the accumulation of β-amyloid peptides in vitro [20].